Introduction {#sec1-1}
============

Age is an important prognostic factor in traumatic brain injury (TBI).\[[@ref1][@ref2][@ref3][@ref4]\] The management of TBI in the elderly (age ≥ 65 years according to the World Health Organization) is challenging and wrought with dilemmas. While surgical intervention is indicated for most young patients, justifications for aggressive therapies in the elderly with poor neurological status are subject to debate and controversies. Despite initially successful treatment, the functional outcomes of elderly patients are often unsatisfactory mainly due to significant primary and secondary brain insults, co-existing medical illnesses and poor rehabilitation potential. While over 75% of those aged 64 or below were able to return to the home after TBI, only around 50% of those older than 65 could do so.\[[@ref5]\]

Traumatic brain injury in the elderly is becoming a major concern in view of the rapidly aging populations. According to the WHO, from 2000 to 2050, the world\'s population aged 60 and above will more than triple from 600 million to 2 billion.\[[@ref6]\] In this locality, elderly people accounted for 12.6% (0.88 million) of the total population in mid-2008.\[[@ref7]\] This is expected to increase to 14% and 27% by 2016 and 2033, respectively.\[[@ref8]\] In Australia, the number of hospital admissions due to TBI in the elderly has been rising over the past 10-year, with the fastest rate of growth seen in those aged above 70.\[[@ref9]\] This group of patients is likely to place an increasing demand on medical expertise and healthcare resources. Outcome analysis of our current practice will serve to inform our future decision-makings on clinical, socioeconomical and ethical grounds. Our institution has not used age as a primary selection criterion for providing operative interventions for head-injured patients. In the present study, we reviewed the outcomes of those aged 65 or above who had undergone surgery for TBI, and investigate for factors that may be predictive of their outcomes.

Materials and Methods {#sec1-2}
=====================

Patient population {#sec2-1}
------------------

This was a retrospective study of a cohort of consecutive patients aged 65 or above who had undergone neurosurgical operations for TBI over a 4-year period at a designated trauma center. All patients received care from a multidisciplinary hospital trauma team upon admission that included emergency physicians, general and orthopedic surgeons, neurosurgeons, anesthesiologists and intensivists. Clinical management was protocol-driven and followed the Advanced Trauma Life Support guidelines.

Neurosurgical management {#sec2-2}
------------------------

The indications for operative interventions remained the same throughout the study period. Age was not a primary inclusion or exclusion criterion. Patients who had sizable hematoma with thickness ≥10 mm and/or midline shift (MLS) \>5 mm on computerized tomography (CT) would undergo craniotomy/craniectomy together with intracranial pressure (ICP) monitoring. Patients who did not have significant intracranial mass lesions but whose Glasgow Coma scores (GCSs) were \<9 would receive endotracheal intubation, artificial ventilation, sedation and external ventricular drainage (EVD) performed in the operating theatre for ICP monitoring and drainage if necessary. The exclusion criteria for surgical intervention included bilateral fixed and dilated pupils and unstable hemodynamics. All patients received perioperative prophylactic antibiotics and anticonvulsant medications. Intravenous mannitol was used for raised ICP. For patients who were taking antiplatelet agents (e.g. aspirin clopidogrel) or anticoagulants (e.g. warfarin), platelet concentrates and fresh frozen plasma would be given prior to and during operations. All patients received postoperative care in the Intensive Care Unit (ICU). Temporary tracheostomy was performed if mechanical ventilation was required for more than 5 days. EVD would be opened for drainage for raised ICP.

Data analysis {#sec2-3}
-------------

Injury severity was assessed using the admission GCS, pupillary response to light, and CT findings. Severity of head injury was classified based on admission GCS as mild (GCS =13-15), moderate (GCS =9-12), and severe (GCS =3-8). Patients' premorbid conditions, including histories of stroke, hypertension (HT), diabetes mellitus (DM), ischemic heart disease, chronic obstructive airway disease, and the use of antiplatelet agent/anticoagulant were recorded. Clinical outcome measures were the GCS and Glasgow outcome score (GOS) upon hospital discharge. Patients with GOS of 4 or 5 were classified as having "good outcome" and those with GOS of 1-3 as "poor outcome." We performed a subgroup analysis for prognostic factors between these two groups, as well as for hospital mortalities (GOS = 1 versus GOS = 2-5).

Statistical method {#sec2-4}
------------------

Chi-square and Fisher\'s exact tests were used for analyzing categorical data. Continuous valuables were analyzed using the Student\'s *t*-test. Binary logistic regression was performed using (i) Hospital mortality and (ii) Good/poor outcomes as dependent variables. *P* ≤ 0.05 was considered as statistically significant. Statistical tests were performed using IBM SPSS Statistics for Windows, Version 19.0. Armonk, NY: IBM Corp. (IBM, USA).

Results {#sec1-3}
=======

Patient characteristics {#sec2-5}
-----------------------

There were 68 patients, including 45 (66.2%) men and 23 (33.8%) women. The mean age was 76.7 years (range: 65-91 years). The most common cause of injury was the fall (70.6%). The median GCS upon admission was 8 (range: 3-15). Severe, moderate and mild head injuries occurred in 42 (61.8%), 13 (19.1%) and 13 (19.1%) patients, respectively. The majority of patients (*n* = 38) had normal pupillary responses, 17 had abnormal responses on one side, and 13 had bilateral abnormal responses (but not both fixed and dilated). Extracranial injuries occurred in 15 (22.1%) of patients \[[Table 1](#T1){ref-type="table"}\]. 27.9% patients were taking antiplatelet, anticoagulant or both at the time of injury \[[Table 2](#T2){ref-type="table"}\].
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Patients' demographics against survival and clinical outcome
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Patients' comorbidities and antiplatelet/anticoagulant against survival and clinical outcome

![](AJNS-12-37-g002)

Computerized tomography findings {#sec2-6}
--------------------------------

The commonest intracranial lesion was acute subdural hematoma (ASDH) (*n* = 49 or 72%), followed by traumatic intracerebral hemorrhage (TICH) (*n* = 12 or 17.6%). The majority (*n* = 49 or 72.1%) of patients harbored more than one pathology; pure ASDH and pure TICH occurred in 16 (23.5%) and three (4.4%) patients, respectively. Basal cistern obliteration and significant MLS occurred in 42 (61.8%) and 46 (67.6%) of patients, respectively. Of all 68 patients, 61 (89.7%) received craniotomy or craniectomy, and 7 (10.3%) underwent EVD insertion only \[[Table 1](#T1){ref-type="table"}\].

Patient outcome {#sec2-7}
---------------

A total of 38 patients died (GOS = 1), yielding a hospital mortality rate of 55.9%. Of the 30 patients who survived, the median GCS upon discharge from hospital was 14 (range: 8-15). GOS of 5 or 4 (i.e. "good outcome") were achieved in 11 (16.2%) and 6 (8.8%) patients, respectively. 12 (17.6%) were severely disabled (GOS = 3) and 1 (1.5%) was vegetative (GOS = 2). The survival rate within the 65-74 years age group was 59.3% (*n* = 16), with 25.9% (*n* = 7) achieving good outcome. For the older age group of 75-84 years, the survival rate decreased to 32.4% (*n* = 11), with good outcome achieved in 23.5% (*n* = 8) of patients. Outcome was significantly better in patients with mild head injury, with the rates of survival and good outcome being 92.3% (*n* = 12) and 76.9% (*n* = 10), respectively (*P* ≤ 0.001) \[[Table 3](#T3){ref-type="table"}\].
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Severity of head injury versus survival rate and good outcome rate in different age groups
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Risk factors for mortalities {#sec2-8}
----------------------------

Comparing between patients who survived (GOS = 2-5) and those who died (GOS = 1), older age (*P* = 0.026), significant MLS (*P* = 0.025), cisternal obliteration (*P* ≤ 0.001), one or more abnormal pupillary responses (*P* ≤ 0.001), lower preoperative GCS (*P* ≤ 0.001), and ASDH as the leading pathology (*P* = 0.001), were correlated with hospital mortalities. Gender, laterality of TBI, preexisting medical morbidities, use of antiplatelet or anticoagulant, and coexisting extracranial injuries were not associated with mortality. On binary logistic regression analysis, however, female gender (coefficient: 3.707, odds ratio \[OR\]: 40.751, *P* = 0.032) was positively correlated with survival. Older age (coefficient: −0.329, OR: 0.720, *P* = 0.008), cisternal obliteration on CT (coefficient: −3.835, OR: 0.008, *P* = 0.010), ASDH as leading pathology (coefficient: −4.846, OR: 0.008, *P* = 0.016), moderate (coefficient: −6.895, OR: 0.001, *P* = 0.016), and severe head injuries (coefficient: −5.446, OR: 0.004, *P* = 0.009) were negatively associated with survival.

Risk factors for poor clinical outcome {#sec2-9}
--------------------------------------

By categorizing outcomes by GOS (1-3 vs. 4-5), lower preoperative GCS (*P* ≤ 0.001), significant MLS (*P* = 0.036), cisternal obliteration (*P* ≤ 0.001), and pupillary abnormalities (*P* = 0.039) were associated with poor outcome (GOS = 1-3). Age and the type of lesion did not show significant correlations. On binary logistic regression analysis, moderate (coefficient: −3.172, OR: 0.024, *P* = 0.004) and severe head injuries (coefficient: −2.423, OR: 0.089, *P* = 0.032), cisternal obliteration (coefficient: −3.002, OR: 0.050, *P* = 0.004) were negatively correlated with good outcome.

Impact of age and severity of head injury {#sec2-10}
-----------------------------------------

Elderly patients below 85-year-old had more than 50% chance of survival if suffering from mild or moderate head injuries. However, good outcome was achieved in only 15.4% (*n* = 2) and 11.9% (*n* = 5) of the respective subgroups of patients. This compared with a 76.9% rate of a good outcome in those suffering from mild head injury. For the age ≥ 85, there was no survivor after moderate to severe head injuries. Overall, mild head injury had the highest survival rate and was most likely to be associated with good outcome (*P* ≤ 0.001) \[[Table 3](#T3){ref-type="table"}\].

Impact of age and pupillary responses {#sec2-11}
-------------------------------------

Overall, normal bilateral response was associated with better survival (*P* ≤ 0.001) as well as clinical outcome (*P* = 0.039) \[[Table 4](#T4){ref-type="table"}\]. Normal bilateral pupillary response was significantly associated with higher survival rates in the 65-74 (*P* = 0.002) and 75-84 (*P* = 0.016) age groups, as well as good outcome in the 75-84 group (*P* = 0.039). For the age ≥ 85 years, the patient number was too small to draw significant conclusion. The presence of one abnormal pupil reduced by around one-third the overall chance of survival (from 65.8% to 23.5%) and good outcome (from 36.8% to 11.8%). Provided both pupils were normal, age 65-74 had a much higher survival rate of 92.3% compared with around 50% in age 75-84 and age 85 years, which again stressed the importance of age.
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Pupillary response versus survival and clinical outcome in different age group
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Impact of age and computerized tomography findings {#sec2-12}
--------------------------------------------------

Of the 36 patients who had coexisting MLS and cisternal obliteration on CT, only nine (25%) survived, and three (8.3%) had good clinical outcome. Of the 10 patients who had MLS without cistern obliteration, seven (70%) survived and five (50%) had a good outcome. Six patients had cistern obliteration without MLS, only one survived and had a poor outcome.

Discussion {#sec1-4}
==========

Fall is the most common case of TBI in the elderly, and around 13% of these patients would require hospital admission.\[[@ref10]\] Over 70% of our patients suffered from the fall that was consistent with the findings from other reports.\[[@ref9][@ref11][@ref12]\] Similarly, ASDH was the most common pathology and was the leading cause of mortality.\[[@ref9][@ref12]\] Age is a well-recognized prognostic factor for TBI. However, for patients with aged above 65, more detailed analysis is lacking as most reported studies focused mainly on comparisons between young (age \< 65 years) and elderly patients (age ≥ 65 years).\[[@ref11][@ref13][@ref14]\] It remains unclear whether and how more advanced age within the elderly group would affect clinical outcome. Lau *et al*. had reported no difference in mortality rates between different age groups. Age only affected the need of rehabilitation.\[[@ref15]\] However, in that study, patients were divided into those younger than 50 and those older than 80, with 30-day mortality as the main treatment outcome. Mortalities beyond 30-day due to complications, which were more common in the elderly, were not assessed.

With our increasingly aging populations, more in-depth stratifications are urgently needed. We found that, within the elderly population, more advanced age itself was a risk factor for mortality but was not found to be an independent risk factor for poor outcome. Patients aged 75-84 with normal bilateral pupillary responses could achieve good survival in 52.6% of cases, and around one-third had good clinical outcome. For patients age ≥ 85 years old, provided they had normal pupils upon presentation, one-third of them could have good clinical outcome. Despite our small sample size, it may be concluded that even for very advance age, operative interventions may still provide benefit. On the other hand, loss of pupillary response of at least one eye in aged ≥ 85 signified extremely poor prognosis.

Preoperative GCS was found to be a major prognostic factor as reported by other previous studies.\[[@ref1][@ref13][@ref15][@ref16]\] Good clinical outcome and high survival rates were observed for patients with minor TBI (GCS = 13-15). With GCS below 12, the rates of both good clinical outcome and survival decreased markedly, particularly in the over - 85 age group in which the chance of survival was minimal. Pupillary response to light was another important factor. It has been shown that in young patients, normal pupillary responses were associated with an overall mortality rate of 23.5%, which compared with up to 79.7% when both pupils were abnormal.\[[@ref4]\] In addition, good pupillary response was also associated with good GOS.

Significant MLS and cisternal obliteration on CT are known to predictive of poor outcome.\[[@ref16]\] In Marshall\'s study, cistern obliteration (Diffuse Injury III) and MLS (Diffuse Injury IV) were associated with mortality rates of 34% and 56.2%, respectively.\[[@ref17]\] In comparison, five out of six of our patients with cisternal obliteration on the initial CT died. The mortality rate of those that had MLS with or without co-existing cistern obliteration was 65.2%. The higher mortality rates in our cohort may be due to the patients' more advanced age as well as differences in their intracranial pathologies. Marshall\'s grading focused on diffuse brain injury, whereas ASDH was the leading pathology in our cohort. Another recent study on patients with intra-cranial hematomas that required craniotomy also showed that MLS was associated with a higher mortality rate and the lower chance to return to preoperative baseline.\[[@ref10]\]

It was somewhat surprising that medical comorbidities were not associated with mortalities in the present study. Similar findings have been reported, which showed that coexisting DM, HT and coronary artery disease did not increase mortality, the need of rehabilitation nor ability to return to baseline.\[[@ref15]\] DM and coronary artery disease were associated with longer ICU and hospital stay while HT only affected hospital stay without prolong the ICU stay.\[[@ref15]\] These may be due to the successful management of these co-morbidities in modern ICU and/or the overwhelming influences from other prognostic factors. It must be emphasized that our study only captured a limited number of preexisting disease. Other common conditions such as renal disease, cerebral degeneration, malignancies that previously considered terminal but are now becoming chronic illnesses, may yet have a significant impact on patient outcome.

The effect of concurrent antiplatelet agents and anticoagulants be controversial. It had been shown that anticoagulant use was associated with a 38% mortality rate, compared with 8% in nonusers after TBI.\[[@ref18]\] Another retrospective study also demonstrated preinjury anticoagulation use was predictive of survival.\[[@ref19]\] In contrast, it has been shown that clopidogrel, aspirin or warfarin (CAW) did not result in higher mortality rates.\[[@ref3]\] Others reported that only clopidogrel had negative impact on survival but not aspirin or warfarin.\[[@ref20]\] The discrepancy of these reports may result from a number of factors. Firstly, the definition of anticoagulation was not uniform. Some authorities considered warfarin, clopidogrel and aspirin as a single entity of anticoagulation, or CAW.\[[@ref3][@ref21]\] Others included only warfarin under anticoagulants.\[[@ref18][@ref20]\] Second, the effects of these medications were not always studied separately. Mortality was found to be related to the patients' coagulation profiles such as the International Normalizing ratio (INR).\[[@ref12][@ref19]\] An INR greater than two was associated with higher mortality, while warfarin users with INR below two had no difference with control.\[[@ref21]\] Third, many reported studies included all patients with TBI in which the majority of patients suffered from mild head injury without the need for operative interventions. In contrast, study focused on patients who required surgery like ours had a high percentage of patients with severe head injury.\[[@ref15]\] Our results were compatible with studies that only included patients undergoing operative intervention, and we found that the use of anticoagulant did not increase mortality rate. In that study, they showed that the anticoagulant only increased complication rate and length of hospital stay.

The main limitations of our study included a lack of comparison with patients on nonoperative management. This latter group included patients with good GCS whose intracranial mass lesions showed borderline mass effect on CT. The decision to provide operative interventions were primarily based on individual physicians' clinical judgments and this may result in sampling bias for our study. Another limitation was the lack of longitudinal follow-up on delayed mortalities and survivors' functional outcome and quality-of-life. Our sample size is small, only one single institution was involved, and there were too few patients in the group with age over 85-year-old. The patients were highly heterogeneous in terms of their intracranial pathologies. The length of stay and cost of hospital, as well as the impact on the patients' families and communities, were also not addressed as many survivors were lost follow-up as they moved to mainland China for care after discharge.

In conclusion, age is an important prognostic factor in TBI. Within the elderly population, more advanced age was found to be associated with progressively worse outcome. However, a subgroup patients aged below 85 would survive and could achieve good clinical outcome, including those with moderate and severe TBI. The prognosis of those aged over 85 with moderate or severe head injuries was extremely poor. The severities of injury, pupillary reactions and CT findings contributed as other significant factors which should be considered when during clinical decision-making.
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